Ashkon Software







 

NSPR Stock - InspireMD, Inc.


NSPR Stock Chart

NSPR Profile

InspireMD, Inc. logo

InspireMD, Inc. is a prominent medical device company specializing in advanced technologies for the treatment of vascular and coronary diseases. The company is renowned for its proprietary MicroNet stent platform technology, which addresses a range of cardiovascular conditions. InspireMD’s innovative solutions are available across Europe, Latin America, the Middle East, and Asia Pacific, reflecting its extensive international reach and commitment to improving patient outcomes worldwide.

The company's flagship product, the CGuard carotid embolic prevention system, is designed to prevent embolic events during carotid artery procedures. This system leverages the MicroNet technology to enhance protection and reduce complications associated with carotid interventions. Another key offering, the MGuard Prime embolic protection system, is used in treating patients with acute coronary syndromes, including acute myocardial infarction, as well as in saphenous vein graft coronary interventions and bypass surgeries. This system is engineered to safeguard against embolic events during complex coronary procedures.

In addition to its existing product line, InspireMD is developing the PVGuard, a novel MicroNet mesh sleeve combined with a self-expandable stent. This product aims to address peripheral vascular conditions by providing enhanced protection and support in various vascular applications. The PVGuard is in the development stage, representing the company’s ongoing efforts to expand its portfolio and deliver cutting-edge solutions for peripheral vascular health.

InspireMD sells its products through a network of local distributors, facilitating widespread availability and support for its advanced medical technologies. Established in 2005 and headquartered in Tel Aviv-Yafo, Israel, the company has built a reputation for innovation in the medical device industry. InspireMD continues to focus on developing and commercializing state-of-the-art solutions to meet the evolving needs of cardiovascular and vascular disease management.

NSPR Revenue Chart

NSPR Earnings


 

Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer